Other Species / Isoforms
  KPNA2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MstNENANt
0 1
KPNA2 (human) ______MstNENANt S2-p
KPNA2 (mouse) ______MSTNENANL S2
KPNA2 (rat) ______MSTNENANS S2
T3-p
_____MstNENANtP
0 1
KPNA2 (human) _____MstNENANtP T3-p
KPNA2 (mouse) _____MSTNENANLP T3
KPNA2 (rat) _____MSTNENANST T3
T9-p
stNENANtPAARLHR
Upstream
Downstream
1 9
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • chromatin organization, altered
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • purvalanol
KPNA2 (human) stNENANtPAARLHR T9-p
KPNA2 (mouse) STNENANLPAARLNR L9
KPNA2 (rat) STNENANSTAARLNR S9
K20-ub
RLHRFKNkGkDsTEM
0 1
KPNA2 (human) RLHRFKNkGkDsTEM K20-ub
KPNA2 (mouse) RLNRFKNKGKDsTEM K20
KPNA2 (rat) RLNRFKNKGKDSTEM K20
K22-ac
HRFKNkGkDsTEMRR
Upstream
Downstream
4 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
Treatment
  • peptide_antagonist
  • trichostatin_A
KPNA2 (human) HRFKNkGkDsTEMRR K22-ac
KPNA2 (mouse) NRFKNKGKDsTEMRR K22
KPNA2 (rat) NRFKNKGKDSTEMRR K22
S24-p
FKNkGkDsTEMRRRR
0 3
KPNA2 (human) FKNkGkDsTEMRRRR S24-p
KPNA2 (mouse) FKNKGKDsTEMRRRR S24-p
KPNA2 (rat) FKNKGKDSTEMRRRR S24
K40-ub
EVNVELRkAKKDDQM
0 1
KPNA2 (human) EVNVELRkAKKDDQM K40-ub
KPNA2 (mouse) EVNVELRKAKKDEQM K40
KPNA2 (rat) EVNVELRKAKKDDQM K40
K49-ub
KKDDQMLkRRNVssF
0 2
KPNA2 (human) KKDDQMLkRRNVssF K49-ub
KPNA2 (mouse) KKDEQMLKRRNVSsF K49
KPNA2 (rat) KKDDQMLKRRNVSSF K49
S54-p
MLkRRNVssFPDDAt
Upstream
0 3
Kinase, in vitro:
  • Chk1 (human)
KPNA2 (human) MLkRRNVssFPDDAt S54-p
KPNA2 (mouse) MLKRRNVSsFPDDAt S54
KPNA2 (rat) MLKRRNVSSFPDDAT S54
S55-p
LkRRNVssFPDDAts
0 9
KPNA2 (human) LkRRNVssFPDDAts S55-p
KPNA2 (mouse) LKRRNVSsFPDDAts S55-p
KPNA2 (rat) LKRRNVSSFPDDATs S55
T61-p
ssFPDDAtsPLQENR
Upstream
0 18
Treatment
  • metastatic potential
KPNA2 (human) ssFPDDAtsPLQENR T61-p
KPNA2 (mouse) SsFPDDAtsPLQENR T61-p
KPNA2 (rat) SSFPDDATsPLQENR T61
S62-p
sFPDDAtsPLQENRN
Upstream
Downstream
2 70
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • chromatin organization, altered
  • cytoskeletal reorganization
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Regulatory protein:
  • PRP4 (human)
Treatment
  • anti-CD3
  • metastatic potential
  • nocodazole
  • purvalanol
  • quinalizarin
KPNA2 (human) sFPDDAtsPLQENRN S62-p
KPNA2 (mouse) sFPDDAtsPLQENRN S62-p
KPNA2 (rat) SFPDDATsPLQENRN S62-p
T73-p
ENRNNQGtVNWsVDD
0 5
KPNA2 (human) ENRNNQGtVNWsVDD T73-p
KPNA2 (mouse) ENRNNQGTVNWSVED T73
KPNA2 (rat) ENRNNQGTVNWSVED T73
S77-p
NQGtVNWsVDDIVkG
0 1
KPNA2 (human) NQGtVNWsVDDIVkG S77-p
KPNA2 (mouse) NQGTVNWSVEDIVKG S77
KPNA2 (rat) NQGTVNWSVEDIVKG S77
K83-ub
WsVDDIVkGINSsNV
0 5
KPNA2 (human) WsVDDIVkGINSsNV K83-ub
KPNA2 (mouse) WSVEDIVKGINSNNL K83
KPNA2 (rat) WSVEDIVKGINSNNL K83
K83-sm
WsVDDIVkGINSsNV
0 1
KPNA2 (human) WsVDDIVkGINSsNV K83-sm
KPNA2 (mouse) WSVEDIVKGINSNNL K83
KPNA2 (rat) WSVEDIVKGINSNNL K83
S88-p
IVkGINSsNVENQLQ
0 1
KPNA2 (human) IVkGINSsNVENQLQ S88-p
KPNA2 (mouse) IVKGINSNNLESQLQ N88
KPNA2 (rat) IVKGINSNNLESQLQ N88
K102-ub
QATQAARkLLsREkQ
0 1
KPNA2 (human) QATQAARkLLsREkQ K102-ub
KPNA2 (mouse) QATQAARKLLSREkQ K102
KPNA2 (rat) QATQAARKLLSREKQ K102
S105-p
QAARkLLsREkQPPI
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • AMPKA1 (human)
Putative in vivo kinases:
  • AMPKA1 (human)
KPNA2 (human) QAARkLLsREkQPPI S105-p
KPNA2 (mouse) QAARKLLSREkQPPI S105
KPNA2 (rat) QAARKLLSREKQPPI S105
K108-ub
RkLLsREkQPPIDNI
0 8
KPNA2 (human) RkLLsREkQPPIDNI K108-ub
KPNA2 (mouse) RKLLSREkQPPIDNI K108-ub
KPNA2 (rat) RKLLSREKQPPIDNI K108
K108-sm
RkLLsREkQPPIDNI
0 1
KPNA2 (human) RkLLsREkQPPIDNI K108-sm
KPNA2 (mouse) RKLLSREKQPPIDNI K108
KPNA2 (rat) RKLLSREKQPPIDNI K108
K123-ub
IRAGLIPkFVsFLGR
0 4
KPNA2 (human) IRAGLIPkFVsFLGR K123-ub
KPNA2 (mouse) IRAGLIPKFVSFLGK K123
KPNA2 (rat) IRAGLIPKFVSFLGK K123
K123-sm
IRAGLIPkFVsFLGR
0 1
KPNA2 (human) IRAGLIPkFVsFLGR K123-sm
KPNA2 (mouse) IRAGLIPKFVSFLGK K123
KPNA2 (rat) IRAGLIPKFVSFLGK K123
S126-p
GLIPkFVsFLGRtDC
0 5
KPNA2 (human) GLIPkFVsFLGRtDC S126-p
KPNA2 (mouse) GLIPKFVSFLGKTDC S126
KPNA2 (rat) GLIPKFVSFLGKTDC S126
T131-p
FVsFLGRtDCSPIQF
0 1
KPNA2 (human) FVsFLGRtDCSPIQF T131-p
KPNA2 (mouse) FVSFLGKTDCSPIQF T131
KPNA2 (rat) FVSFLGKTDCSPIQF T131
T145-p
FESAWALtNIASGtS
0 1
KPNA2 (human) FESAWALtNIASGtS T145-p
KPNA2 (mouse) FESAWALTNIASGTS T145
KPNA2 (rat) FESAWALTNIASGTS T145
T151-p
LtNIASGtSEQTKAV
0 1
KPNA2 (human) LtNIASGtSEQTKAV T151-p
KPNA2 (mouse) LTNIASGTSEQTKAV T151
KPNA2 (rat) LTNIASGTSEQTKAV T151
K202-ub
VFRDLVIkyGAVDPL
0 8
KPNA2 (human) VFRDLVIkyGAVDPL K202-ub
KPNA2 (mouse) AFRDLVIkHGAIDPL K202-ub
KPNA2 (rat) VFRDLVIKHGAIDPL K202
Y203-p
FRDLVIkyGAVDPLL
0 1
KPNA2 (human) FRDLVIkyGAVDPLL Y203-p
KPNA2 (mouse) FRDLVIkHGAIDPLL H203
KPNA2 (rat) FRDLVIKHGAIDPLL H203
Y225-p
MSSLACGyLRNLTWT
0 1
KPNA2 (human) MSSLACGyLRNLTWT Y225-p
KPNA2 (mouse) LSTLACGYLRNLTWT Y225
KPNA2 (rat) LSSLACGYLRNLTWT Y225
K240-ub
LSNLCRNkNPAPPID
0 25
KPNA2 (human) LSNLCRNkNPAPPID K240-ub
KPNA2 (mouse) LSNLCRNkNPAPPLD K240-ub
KPNA2 (rat) LSNLCRNKNPAPPLD K240
K240-sm
LSNLCRNkNPAPPID
0 1
KPNA2 (human) LSNLCRNkNPAPPID K240-sm
KPNA2 (mouse) LSNLCRNKNPAPPLD K240
KPNA2 (rat) LSNLCRNKNPAPPLD K240
T255-p
AVEQILPtLVRLLHH
0 1
KPNA2 (human) AVEQILPtLVRLLHH T255-p
KPNA2 (mouse) AVEQILPTLVRLLHH T255
KPNA2 (rat) AVEQILPTLVRLLHH T255
K291-ub
ERIGMVVkTGVVPQL
0 9
KPNA2 (human) ERIGMVVkTGVVPQL K291-ub
KPNA2 (mouse) ERIEMVVKKGVVPQL K291
KPNA2 (rat) ERIEMVVKKGVVPQL K291
K300-ub
GVVPQLVkLLGAsEL
0 9
KPNA2 (human) GVVPQLVkLLGAsEL K300-ub
KPNA2 (mouse) GVVPQLVkLLGATEL K300-ub
KPNA2 (rat) GVVPQLVKLLGATEL K300
S305-p
LVkLLGAsELPIVtP
0 1
KPNA2 (human) LVkLLGAsELPIVtP S305-p
KPNA2 (mouse) LVkLLGATELPIVTP T305
KPNA2 (rat) LVKLLGATELPIVTP T305
T311-p
AsELPIVtPALRAIG
0 1
KPNA2 (human) AsELPIVtPALRAIG T311-p
KPNA2 (mouse) ATELPIVTPALRAIG T311
KPNA2 (rat) ATELPIVTPALRAIG T311
K348
PSLLTNPKtNIQkEA
0 4
KPNA2 (human) PSLLTNPKtNIQkEA K348
KPNA2 (mouse) PSLLTNPkTNIQKEA K348-ub
KPNA2 (rat) PSLLTNPKTNIQKEA K348
K348-sm
PSLLTNPktNIQkEA
0 1
KPNA2 (human) PSLLTNPktNIQkEA K348-sm
KPNA2 (mouse) PSLLTNPKTNIQKEA K348
KPNA2 (rat) PSLLTNPKTNIQKEA K348
T349-p
SLLTNPktNIQkEAT
Upstream
0 1
Treatment
  • dasatinib
KPNA2 (human) SLLTNPktNIQkEAT T349-p
KPNA2 (mouse) SLLTNPkTNIQKEAT T349
KPNA2 (rat) SLLTNPKTNIQKEAT T349
K353-ub
NPktNIQkEATWTMs
0 12
KPNA2 (human) NPktNIQkEATWTMs K353-ub
KPNA2 (mouse) NPkTNIQKEATWTMS K353
KPNA2 (rat) NPKTNIQKEATWTMS K353
S360-p
kEATWTMsNItAGRQ
0 1
KPNA2 (human) kEATWTMsNItAGRQ S360-p
KPNA2 (mouse) KEATWTMSNITAGRQ S360
KPNA2 (rat) KEATWTMSNITAGRQ S360
T363-p
TWTMsNItAGRQDQI
Upstream
0 1
Treatment
  • dasatinib
KPNA2 (human) TWTMsNItAGRQDQI T363-p
KPNA2 (mouse) TWTMSNITAGRQDQI T363
KPNA2 (rat) TWTMSNITAGRQDQI T363
K388-ub
FLVSVLSkADFkTQK
0 1
KPNA2 (human) FLVSVLSkADFkTQK K388-ub
KPNA2 (mouse) FLVGVLSKADFKTQK K388
KPNA2 (rat) FLVGVLSKADFKTQK K388
K392-ub
VLSkADFkTQKEAVW
0 2
KPNA2 (human) VLSkADFkTQKEAVW K392-ub
KPNA2 (mouse) VLSKADFKTQKEAAW K392
KPNA2 (rat) VLSKADFKTQKEAAW K392
K459-ub
EKLGETEkLSIMIEE
0 4
KPNA2 (human) EKLGETEkLSIMIEE K459-ub
KPNA2 (mouse) EKLGETEkLSIMIEE K459-ub
KPNA2 (rat) EKLGETEKLSIMIEE K459
S483-p
LQNHENEsVYkASLs
0 2
KPNA2 (human) LQNHENEsVYkASLs S483-p
KPNA2 (mouse) LQRHENEsVYkASLN S483-p
KPNA2 (rat) LQSHENESVYKASLN S483
K486-ub
HENEsVYkASLsLIE
0 8
KPNA2 (human) HENEsVYkASLsLIE K486-ub
KPNA2 (mouse) HENEsVYkASLNLIE K486-ub
KPNA2 (rat) HENESVYKASLNLIE K486
S490-p
sVYkASLsLIEkYFS
Upstream
0 20
Regulatory protein:
  • PLK1 (human)
Treatment
  • BI2536
  • vemurafenib
KPNA2 (human) sVYkASLsLIEkYFS S490-p
KPNA2 (mouse) sVYkASLNLIEKYFS N490
KPNA2 (rat) SVYKASLNLIEKYFS N490
K494-sm
ASLsLIEkYFSVEEE
0 1
KPNA2 (human) ASLsLIEkYFSVEEE K494-sm
KPNA2 (mouse) ASLNLIEKYFSVEEE K494
KPNA2 (rat) ASLNLIEKYFSVEEE K494
S512-p
NVVPETTsEGYTFQV
0 1
KPNA2 (human) NVVPETTsEGYTFQV S512-p
KPNA2 (mouse) NVVPETTSEGFAFQV S512
KPNA2 (rat) NVVPETTSEGFAFQV S512